BSEBoard Meeting4d ago · 25 Jul 2026, 03:39 pm

SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2026 ,inter alia, to consider and approve Un-audited Financial Results ....

SMS Pharmaceuticals Ltd · 532815

✦ AI SummaryResults

SMS Pharmaceuticals Ltd has scheduled a board meeting on August 1, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 30Th June, 2026

Attachments (1)

📄

741a7a04-3b23-406a-bebd-6d869f89e3d3.pdf

pdf

Download →
View document text
Date: 25th July, 2026 The Manager, The Manager, Corporate Filings Department, Listing Compliance Department, BSE Limited, National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex, Bandra (E), Mumbai- 400 001 Mumbai - 400 051. Security Code: 532815 Symbol: SMSPHARMA Dear Sir/Madam, Sub: Intimation of Board Meeting of SMS Pharmaceuticals Limited (“the Company”) to be held on Saturday, 1st August, 2026. Ref: Regulation 29 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 1st August, 2026 at the Registered Office of the Company situated at 8th Floor, Trendset Jayabheri Connect, Kondapur, Serilingampally, Ranga Reddy Dist., Hyderabad- 500084 Telangana inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the first quarter ended on 30th June, 2026. In accordance with the Company’s Code of Conduct for Prevention of Insider Trading, pursuant to the amended SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company has already intimated its designated persons including directors regarding the closure of the ‘Trading Window’ for trading in the Company's equity shares from 01st July, 2026, it will remain closed up to 03rd August, 2026 (both days inclusive) and shall be re-opened on 04th August, 2026. We request to kindly take note of the same. Thanking you Yours faithfully For SMS Pharmaceuticals Limited Thirumalesh Tumma Company Secretary & Compliance Officer